IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$192M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
157
New
Increased
Reduced
Closed

Top Buys

1
+$24.3M
2
+$22.7M
3
+$20.3M
4
PTCT icon
PTC Therapeutics
PTCT
+$14.6M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$8.84M

Top Sells

1
+$18.5M
2
+$18.4M
3
+$13.9M
4
COGT icon
Cogent Biosciences
COGT
+$12.1M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$12M

Sector Composition

1 Healthcare 99.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
126
Centessa Pharmaceuticals
CNTA
$3.95B
– –
0
CRBP icon
127
Corbus Pharmaceuticals
CRBP
$144M
– –
0
ELDN icon
128
Eledon Pharmaceuticals
ELDN
$199M
– –
-1,000,221
GERN icon
129
Geron
GERN
$938M
– –
-1,600,000
HOOK
130
DELISTED
HOOKIPA Pharma
HOOK
– –
-52,996
HROW icon
131
Harrow
HROW
$1.43B
– –
0
IBB icon
132
iShares Biotechnology ETF
IBB
$8.56B
– –
-5,755
INBX icon
133
Inhibrx
INBX
$1.08B
– –
-42,122
KALV icon
134
KalVista Pharmaceuticals
KALV
$827M
– –
-198,528
KYMR icon
135
Kymera Therapeutics
KYMR
$6.91B
– –
0
LQDA icon
136
Liquidia Corp
LQDA
$2.76B
– –
0
LRMR icon
137
Larimar Therapeutics
LRMR
$453M
– –
0
NUVB icon
138
Nuvation Bio
NUVB
$1.63B
– –
-619,258
NVO icon
139
Novo Nordisk
NVO
$171B
– –
0
PRTA icon
140
Prothena Corp
PRTA
$504M
– –
0
RARE icon
141
Ultragenyx Pharmaceutical
RARE
$2.13B
– –
0
SPRY icon
142
ARS Pharmaceuticals
SPRY
$877M
– –
0
SRPT icon
143
Sarepta Therapeutics
SRPT
$1.66B
– –
-449,087
SRRK icon
144
Scholar Rock
SRRK
$4.84B
– –
-49,179
TEVA icon
145
Teva Pharmaceuticals
TEVA
$38.3B
– –
0
TKNO icon
146
Alpha Teknova
TKNO
$125M
– –
-14,008
TRML
147
DELISTED
Tourmaline Bio
TRML
– –
-67,927
UTHR icon
148
United Therapeutics
UTHR
$21.9B
– –
0
VERA icon
149
Vera Therapeutics
VERA
$2.81B
– –
-14,096
VIGL
150
DELISTED
Vigil Neuroscience
VIGL
– –
-31,360
3 4 5
6
7